The displayed product is our AI-enabled cryomicroneedle painless drug delivery system. It is an innovative drug-device combination platform designed for the storage, transport, and transdermal delivery of insulin, GLP-1, proteins, peptides, mRNA, and living cells. Compared with conventional delivery approaches, the technology offers a minimally invasive and pain free alternative, while helping preserve the activity of sensitive biologics, lower the risk of and insulin resistence. The CMN technology is intended to improve patient compliance, with application in diabetes, obesity.treatment.